SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.370.0%Nov 17 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (404)9/8/1999 1:42:00 PM
From: scaram(o)uche  Read Replies (2) of 1475
 
thanks, PB.......

hematology.org

Scientific Subcommittee on Transplantation Biology
Induction of Mixed Chimerism by Allogeneic Hematopoietic Cell Transplantation

Chair:
Karl G. Blume, M.D., Stanford University, Palo Alto, CA

Speakers:
Karl G. Blume, M.D., Stanford University, Palo Alto,, CA
Introduction: Mixed Chimerism

Samuel Strober, M.D., Stanford University, Palo Alto, CA
Which T Cells Are Needed for Engraftment and Graft-Versus-Tumor Effect?

Megan Sykes, M.D., Harvard Medical School, Boston, MA
From Murine Models of Chimerism to Clinical Transplantation

Rainer F. Storb, M.D., Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA
Mixed Chimerism and Graft-Versus-Tumor Effect - A Curative Concept Derived from the Dog Model
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext